Association of dual-antiplatelet therapy with reduced major adverse cardiovascular events in patients with symptomatic peripheral arterial disease
Ehrin J. Armstrong(University of Denver), John R. Laird(St. Helena Hospital), Gagan D. Singh(University of California, Davis), Heejung Bang(University of California, Davis), Ezra A. Amsterdam(University of California, Davis), Khung Keong Yeo(SingHealth), Julie A. Freischlag(Wake Forest University), David R. Anderson(Dalhousie University)
Cited by 75
Related Papers
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients
|Blood Advances|2019|586
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial
|The Lancet|2013|522
Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Ischemic Stroke in Middle-aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
|Archives of Internal Medicine|2005|280
Functional and Exercise Limitations After a First Episode of Pulmonary Embolism
|CHEST Journal|2016|275